U.S. | Business | Sports | Entertainment

PRIVACY ALERT: ACCU Reference Medical Laboratory Under Investigation for Data Breach of Patient Records

SAN FRANCISCO, July 16, 2025 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to patient information held by ACCU Reference Medical Laboratory, a New Jersey-based full-service medical laboratory.

PRIVACY ALERT: ACCU Reference Medical Laboratory Under Investigation for Data Breach of Patient Records

Ransomware group Qilin reportedly posted unredacted patient health information on its Dark Web site on July 10, 2025. This cyberattack does not appear to be a re-listing of data from the December 2023 cyberattack on ACCU Reference. It appears that ACCU Reference failed to notify patients in 2023 and 2025 that their private information was stolen.

If your personal information was impacted by this incident, you may be at risk of identity theft and other serious violations of your privacy. As a result, you may be entitled to money damages and an injunction requiring changes to ACCU Reference’s cybersecurity practices.

If you received notification of this data breach or are a patient of ACCU Reference and wish to obtain additional information about your legal rights, please contact us today or visit our website at https://www.classactionlawyers.com/acculab.

About Schubert Jonckheer & Kolbe LLP

Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against their officers and directors. The firm is based in San Francisco, and with the help of co-counsel, litigates cases nationwide.

Contact

Sonum Dixit

Schubert Jonckheer & Kolbe LLP

sdixit@sjk.law

Tel: 415-299-8207

Cision View original content:https://www.prnewswire.com/news-releases/privacy-alert-accu-reference-medical-laboratory-under-investigation-for-data-breach-of-patient-records-302506220.html

SOURCE Schubert Jonckheer & Kolbe LLP

Disclaimer: The above press release comes to you under an arrangement with PR Newswire. We takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More